SCHEMBL14375250

SCHEMBL14375250

Cc1nc(N)nc(O)c1CN1CCC(C)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.38
HRH3 Q9Y5N1 2/20 0.37
DHFR P00374 1/20 0.37
ALDH1A1 P00352 5/20 0.37
POLB P06746 4/20 0.37
GAA P10253 2/20 0.37
TSHR P16473 2/20 0.37
KDM4E B2RXH2 2/20 0.36
HPGD P15428 2/20 0.36
MEN1 O00255 1/20 0.36
ESR1 P03372 1/20 0.36
GLA P06280 1/20 0.36
PABPC1 P11940 1/20 0.36
RECQL P46063 1/20 0.36
YWHAG P61981 1/20 0.36
KMT2A Q03164 1/20 0.36
ESR2 Q92731 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MBOAT4 Q96T53 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14375266 0.69 JAK2 (0.44) ACHEHRH3ALDH1A1KDM4EHPGD
SCHEMBL14270034 0.68 TLR8 (0.47) ALDH1A1POLBKDM4ENUDT1
SCHEMBL6314302 0.68 HSP90AA1 (0.41) ACHEHRH3ALDH1A1POLBGAA
SCHEMBL1684911 0.67 TLR8 (0.44) ALDH1A1KDM4ENUDT1
SCHEMBL12424513 0.66 ACHE (0.41) ACHEHRH3ALDH1A1POLBGAA
SCHEMBL12425855 0.66 ALDH1A1 (0.44) ACHEHRH3ALDH1A1TSHRMEN1
SCHEMBL6414929 0.64 TLR8 (0.56)
SCHEMBL14375238 0.64 L3MBTL1 (0.51) ACHEHRH3ALDH1A1POLBGAA
SCHEMBL15214324 0.64 TSHR (0.59) ACHEHRH3ALDH1A1TSHRKDM4E
SCHEMBL5807749 0.63 NPSR1 (0.47) ALDH1A1POLBGAATSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070244133-A1 Thienopyrimidines and Thiazolopyrimidines for Use in Medicine ASTRAZENECA AB (SE) 2007-10-18 US disclosed
US-20070244133-A1 Thienopyrimidines and Thiazolopyrimidines for Use in Medicine ASTRAZENECA AB (SE) 2007-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070244133-A1 Thienopyrimidines and Thiazolopyrimidines for Use in Medicine CXCR4, CXCR1, CXCR3 ACHE 3909/4885HRH3 418/4885DHFR 88/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.